EU approves AstraZeneca’s Tagrisso combined with chemotherapy for EGFRm NSCLC

Annually, there are an estimated 2.4 million people diagnosed with lung cancer across the world, with 80-85% of them diagnosed with NSCLC. Credit: kalhh from Pixabay